<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37318546</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-160X</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Rheumatology international</Title><ISOAbbreviation>Rheumatol Int</ISOAbbreviation></Journal><ArticleTitle>Bilateral central retinal artery occlusion as a presenting manifestation of systemic lupus erythematosus: a case-based review.</ArticleTitle><Pagination><StartPage>1947</StartPage><EndPage>1956</EndPage><MedlinePgn>1947-1956</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00296-023-05365-8</ELocationID><Abstract><AbstractText>Central retinal artery occlusion (CRAO) is an ophthalmic emergency that typically results in permanent vision damage even despite vigorous treatment. In this article, we describe a case of acute vaso-occlusive retinopathy that presented as the primary manifestation of SLE in the absence of elevated levels of APLAs. After treatment with intravenous steroids, immunoglobulin, intrathecal injection of dexamethasone, plasma exchange, and intravenous cyclophosphamide, SLE was well controlled in the patient, but her vision was permanently lost in the left eye. We also go over a brief review of the currently available literature on retinal vaso-occlusive disease present in SLE. The pathology mechanism of CRAO is related to immune complex-mediated "vasculitis", which is typically associated with neuropsychiatric lupus. However, the literature review identified antiphospholipid antibody syndrome (APS) in only 6 of 19 patients, indicating that other mechanisms besides APS are associated with CRAO. Systemic immunosuppression and anticoagulants are required for the treatment of this severe vaso-occlusive retinopathy. Early recognition and aggressive intervention may prevent severe loss of vision.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Xin</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-3447-8892</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Jinhua Municipal Central Hospital, Jinhua Hospital of Zhejiang University, Jinhua, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Xiaowei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Jinhua Municipal Central Hospital, Jinhua Hospital of Zhejiang University, Jinhua, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Jinyu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Eye Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wenwen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chao</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5268-9570</Identifier><AffiliationInfo><Affiliation>Department of Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0003-0720-3188</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yifan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. jingxue@zju.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-9931-4197</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. duyan2014@zju.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>LY20H100007</GrantID><Agency>Natural Science Foundation of Zhejiang Province</Agency><Country/></Grant><Grant><GrantID>LY22H100004</GrantID><Agency>Natural Science Foundation of Zhejiang Province</Agency><Country/></Grant><Grant><GrantID>LY22H120003</GrantID><Agency>Natural Science Foundation of Zhejiang Province</Agency><Country/></Grant><Grant><GrantID>No. 82271817</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Rheumatol Int</MedlineTA><NlmUniqueID>8206885</NlmUniqueID><ISSNLinking>0172-8172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016736" MajorTopicYN="Y">Antiphospholipid Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015356" MajorTopicYN="Y">Retinal Artery Occlusion</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012164" MajorTopicYN="Y">Retinal Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014785" MajorTopicYN="N">Vision, Ocular</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Central retinal artery occlusion</Keyword><Keyword MajorTopicYN="N">Cerebral infarction</Keyword><Keyword MajorTopicYN="N">Corticosteroid</Keyword><Keyword MajorTopicYN="N">Plasma exchange</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>11</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37318546</ArticleId><ArticleId IdType="doi">10.1007/s00296-023-05365-8</ArticleId><ArticleId IdType="pii">10.1007/s00296-023-05365-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. N Engl J Med 358(9):929&#x2013;939</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra071297</ArticleId><ArticleId IdType="pubmed">18305268</ArticleId></ArticleIdList></Reference><Reference><Citation>Dammacco R (2018) Systemic lupus erythematosus and ocular involvement: an overview. Clin Exp Med 18(2):135&#x2013;149</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-017-0479-9</ArticleId><ArticleId IdType="pubmed">29243035</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold DH, Morris DA, Henkind P (1972) Ocular findings in systemic lupus erythematosus. Br J Ophthalmol 56(11):800&#x2013;804</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjo.56.11.800</ArticleId><ArticleId IdType="pubmed">4647128</ArticleId><ArticleId IdType="pmc">1214747</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanham JG, Barrie T, Kohner EM, Hughes GR (1982) SLE retinopathy: evaluation by fluorescein angiography. Ann Rheum Dis 41(5):473&#x2013;478</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.41.5.473</ArticleId><ArticleId IdType="pubmed">7125716</ArticleId><ArticleId IdType="pmc">1001025</ArticleId></ArticleIdList></Reference><Reference><Citation>Read RW (2004) Clinical mini-review: systemic lupus erythematosus and the eye. Ocul Immunol Inflamm 12(2):87&#x2013;99</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273940490895308</ArticleId><ArticleId IdType="pubmed">15512979</ArticleId></ArticleIdList></Reference><Reference><Citation>Stafford-Brady F-J, Urowitz MB, Gladman DD, Easterbrook M (1988) Lupus retinopathy. Patterns, associations, and prognosis. Arthritis Rheum. 31(9):1105&#x2013;10</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780310904</ArticleId><ArticleId IdType="pubmed">3422014</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou X, Zhuang Y, Dong FT, Zhang F, Chen YX (2012) Sequential bilateral central retinal artery occlusion as the primary manifestation of systemic lupus erythematosus. Chin Med J (Engl) 125(8):1517&#x2013;1519</Citation><ArticleIdList><ArticleId IdType="pubmed">22613664</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang G, Shen H, Zhao J, Mao J (2020) Severe vaso-occlusive lupus retinopathy in the early stage of a pediatric patient with systemic lupus erythematosus: a case report. Medicine (Baltimore) 99(16):e19875</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000019875</ArticleId><ArticleId IdType="pubmed">32312013</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer I, Gilad E, Cohen S, Ben Sira I (1985) Combined arterial and venous retinal occlusion as a presenting sign of systemic lupus erythematosus. Ophthalmologica. 191(2):114&#x2013;8</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000309570</ArticleId><ArticleId IdType="pubmed">4058856</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gordon C (2007) Ocular manifestations of systemic lupus erythematosus. Rheumatology (Oxford) 46(12):1757&#x2013;1762</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kem173</ArticleId><ArticleId IdType="pubmed">17681981</ArticleId></ArticleIdList></Reference><Reference><Citation>el Fouad A, Hanane M, Mounir B, Rachid Z, Karim R, Abdelber O (2015) Severe ischemic retinopathy in a patient with systemic lupus erythematosus without antiphospholipid syndrome: A case report. Saudi J Ophthalmol. 29(2):169&#x2013;71</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sjopt.2014.09.005</ArticleId><ArticleId IdType="pubmed">25892939</ArticleId></ArticleIdList></Reference><Reference><Citation>Varma DD, Cugati S, Lee AW, Chen CS (2013) A review of central retinal artery occlusion: clinical presentation and management. Eye (Lond) 27(6):688&#x2013;697</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/eye.2013.25</ArticleId><ArticleId IdType="pubmed">23470793</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua L, Patel K, Corbett JJ (2015) Bilateral central retinal artery occlusion in a patient with systemic lupus erythematosus. J Stroke Cerebrovasc Dis 24(6):e139&#x2013;e141</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2015.02.005</ArticleId><ArticleId IdType="pubmed">25906934</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson AJ, Ordonez NG, Diddie KR, Ernest JT (1979) Immune-complex deposition in the eye in systemic lupus erythematosus. Arch Intern Med 139(11):1312&#x2013;1313</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1979.03630480084026</ArticleId><ArticleId IdType="pubmed">159674</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine RA, Ward PA (1970) Experimental acute immunologic ocular vasculitis. Am J Ophthalmol 69(6):1023&#x2013;1031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9394(70)91052-4</ArticleId><ArticleId IdType="pubmed">4912619</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabs DA, Fine SL, Hochberg MC, Newman SA, Heiner GG, Stevens MB (1986) Severe retinal vaso-occlusive disease in systemic lupus erythematous. Arch Ophthalmol 104(4):558&#x2013;563</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archopht.1986.01050160114025</ArticleId><ArticleId IdType="pubmed">3954661</ArticleId></ArticleIdList></Reference><Reference><Citation>Ish S, Sharma D, Verma R, Kumari S, Garkoti H (2020) Bilateral central retinal artery occlusion - a catastrophic presentation of systemic lupus erythematosus. Oman J Ophthalmol 13(3):149&#x2013;151</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ojo.OJO_133_2019</ArticleId><ArticleId IdType="pubmed">33542604</ArticleId><ArticleId IdType="pmc">7852415</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandran K, Shenoy SB, Kulkarni C, Mathew NR (2020) Bilateral simultaneous central retinal artery occlusion (CRAO) in a patient with systemic lupus erythematosus (SLE). Am J Ophthalmol Case Rep 19:100833</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajoc.2020.100833</ArticleId><ArticleId IdType="pubmed">32904183</ArticleId><ArticleId IdType="pmc">7451415</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang HS, Kang S (2012) Combined central retinal vein and artery occlusion in systemic lupus erythematosus patient. Retin Cases Brief Rep 6(2):187&#x2013;188</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ICB.0b013e31822476d7</ArticleId><ArticleId IdType="pubmed">25390959</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi U, Afroz S, Ranka S, Mba B (2018) Bilateral central retinal artery occlusion from catastrophic antiphospholipid syndrome. BMJ Case Rep 2018:bcr-2018-226463</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2018-226463</ArticleId><ArticleId IdType="pubmed">30420561</ArticleId></ArticleIdList></Reference><Reference><Citation>Parchand SM, Vijitha VS, Misra DP (2017) Combined central retinal artery and vein occlusion in lupus. BMJ Case Rep 2017:bcr2016218848</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2016-218848</ArticleId><ArticleId IdType="pubmed">28073881</ArticleId><ArticleId IdType="pmc">5256535</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiguchi KM, Ito Y, Terasaki H (2013) Bilateral central retinal artery occlusion and vein occlusion complicated by severe choroidopathy in systemic lupus erythematosus. Lupus 22(7):733&#x2013;735</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313490435</ArticleId><ArticleId IdType="pubmed">23681406</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang PC, Chen WS, Lin HY, Lee HM, Chen SJ (2010) Combined central retinal artery and vein occlusion in a patient with systemic lupus erythematosus and anti-phospholipid syndrome. Lupus 19(2):206&#x2013;209</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309345751</ArticleId><ArticleId IdType="pubmed">19880552</ArticleId></ArticleIdList></Reference><Reference><Citation>Bawankar P, Samant P, Lahane S, Jain A, Pathak P (2018) Combined central retinal artery and vein occlusion as the presenting manifestation of systemic lupus erythematosus. Indian J Ophthalmol 66(12):1864</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijo.IJO_996_18</ArticleId><ArticleId IdType="pubmed">30451205</ArticleId><ArticleId IdType="pmc">6256918</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhlaghi M, Abtahi-Naeini B, Pourazizi M (2018) Acute vision loss in systemic lupus erythematosus: bilateral combined retinal artery and vein occlusion as a catastrophic form of clinical flare. Lupus 27(6):1023&#x2013;1026</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203317727602</ArticleId><ArticleId IdType="pubmed">28853639</ArticleId></ArticleIdList></Reference><Reference><Citation>Ameen Ismail A, Sadek SH, Hatata RM (2022) Early onset monocular hydroxychloroquine maculopathy in a systemic lupus erythematosus patient with history of central retinal artery occlusion: a case report. BMC Ophthalmol. 22(1):434</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12886-022-02657-8</ArticleId><ArticleId IdType="pubmed">36376841</ArticleId><ArticleId IdType="pmc">9664730</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendrinos E, Mavrakanas N, Kiel R, Pournaras CJ (2009) Bilateral combined central retinal artery and vein occlusion in systemic lupus erythematosus resulting in complete blindness. Eye (Lond) 23(5):1231&#x2013;1232</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/eye.2008.164</ArticleId><ArticleId IdType="pubmed">18535593</ArticleId></ArticleIdList></Reference><Reference><Citation>Durukan AH, Akar Y, Bayraktar MZ, Dinc A, Sahin OF (2005) Combined retinal artery and vein occlusion in a patient with systemic lupus erythematosus and antiphospholipid syndrome. Can J Ophthalmol 40(1):87&#x2013;89</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0008-4182(05)80126-7</ArticleId><ArticleId IdType="pubmed">15825539</ArticleId></ArticleIdList></Reference><Reference><Citation>Song YH, Kim CG, Kim SD, Kim YY, Choe JY (2001) Systemic lupus erythematosus presenting earlier as retinal vaso-occlusion. Korean J Intern Med 16(3):210&#x2013;213</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjim.2001.16.3.210</ArticleId><ArticleId IdType="pubmed">11769581</ArticleId><ArticleId IdType="pmc">4531720</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibovitch I, Goldstein M, Loewenstein A, Barak A (2001) Combined central retinal artery and vein occlusion in a patient with systemic lupus erythematosus. Rheumatology (Oxford) 40(10):1195&#x2013;1196</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/40.10.1195</ArticleId><ArticleId IdType="pubmed">11600756</ArticleId></ArticleIdList></Reference><Reference><Citation>Damato E, Chilov M, Lee R, Singh A, Harper S, Dick A (2011) Plasma exchange and rituximab in the management of acute occlusive retinal vasculopathy secondary to systemic lupus erythematosus. Ocul Immunol Inflamm 19(5):379&#x2013;381</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09273948.2011.603069</ArticleId><ArticleId IdType="pubmed">21970667</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>